Trial result ·
Effects of mandibular advancement device versus continuous positive airway pressure on cardiac remodeling in obstructive sleep apnea: a randomized CMR substudy.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study looked at people with moderate to severe obstructive sleep apnea. They also had high blood pressure and raised heart risk. It was part of a larger trial called CRESCENT. People were put by chance into one of the treatment groups. In total, 36 people used a mouth device called MAD. Another 49 people used CPAP, an air pressure treatment. Heart scans using magnets were done at the start and after 12 months.
What they found
The scans measured heart size, heart pumping and heart muscle mass. They also measured a sign of spread-out scarring in the heart. After 12 months, this scarring sign went down a bit in both groups. The drop was about the same with MAD and with CPAP. The groups did not differ in changes to heart muscle mass. They also did not differ in heart size or pumping.
What it means for patients
Both treatments were linked to a modest drop in the scarring sign. Neither one seemed better than the other for this sign. Heart muscle mass and pumping did not improve with either treatment. The authors think this is because most hearts looked healthy at the start.
Why it is not certain yet
The groups held 36 and 49 people. Only people who agreed to both scans took part in this part. Most of the people in it were men. The drop in the scarring sign was modest. Follow-up lasted 12 months, so longer effects are not known.
Source
Effects of mandibular advancement device versus continuous positive airway pressure on cardiac remodeling in obstructive sleep apnea: a randomized CMR substudy.
PubMed · PMID 43019196We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Obstructive sleep apnoea publications